Hyponatremic hypochloremic dehydration in children with cystic fibrosis in Slovenia; the incidence and recommendations for prevention and treatment
Abstract
Background: Young children and rarely adolescents with cystic fibrosis can develop hyponatremic hypochloremic dehydration with metabolic alkalosis. The purpose of this article was to review the incidence of this metabolic disorder in our CF patients.
Methods: We investigated the medical records of all children diagnosed with cystic fibrosis who are under follow-up in the CF center at the University Childrenʹs Hospital Ljubljana, and were hospitalised or treated on an outpatient basis due to hyponatremic, hypochloremic dehydration in the period from 2007–2012. Data analysis included clinical and laboratory findings.
Results: A total of 4 children (7.2 %) from Ljubljana CF center (55 patients under the age of 19 years) were enrolled in the study. We observed 5 episodes of hyponatremic hypochloremic dehydration in 4 patients (one boy had two episodes). All were homozigous for ΔF 508 mutation. Two had episodes in summer and two in autumn, so that no season prevalence of its occurence was found. Median age at admission to the hospital due to hyponatremic hypochloremic dehydration was 7 months (range 4–34). One boy had a hypovolemic shock at the time of admission to the hospital.
Conclusions: The results of our study show that dehydration with hypoelectrolytaemia is a rare complication in children with CF in Slovenia, but due to the severity of clinical signs it is an important disorder. Vomiting and fatigue are the warning signs that should alert parents and physicians to consider the possibility of this complication which can be prevented by proper hydration and salt replacement. If left untreated, it can cause seizures, arrhythmias and even death.
Downloads
References
Ratjen F, Döring G. Cystic fibrosis. Lancet 2003; 361: 681–9.
Kerem B, Rommens JM, Buchanan JA et al. Identification of the cystic fibrosis gene:genetic analysis. Science 1989; 254: 1073–80.
Ratjen FA. Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care 2009; 54: 595–602.
Quinton PM. Cystic fibrosis: lessons from the sweat gland. Physiology (Bethesda). 2007; 22: 212–25.
Kennedy JD, Dinwiddie R, Daman-Willems C et al. Pseudo-Bartter’s syndrome in cystic fibrosis. Arch Dis Child 1990; 65: 786–7.
Beckerman RC, Taussig LM. Hypoelectrolytemia and metabolic alkalosis in infants with cystic fibrosis. Pediatrics 1979; 63: 580–3.
Fustik S, Pop-Jordanova N, Slaveska N, Koceva S, Efremov G. Metabolic alkalosis with hypoelectrolytemia in infants with cystic fibrosis. Pediatr Int 2002; 44: 289–92.
Yalçin E, Kiper N, Doğru D et al. Clinical features and treatment approaches in cystic fibrosis with pseudo-Bartter syndrome. Ann Trop Pediatr 2005; 25: 119–24.
Spasovski G, Vanholder R, Allolio B, et al; Hyponatraemia Guideline Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014; 170:G1–47.
Sojo A, Rodriguez-Soriano J, Vitoria JC, Vazquez C, Ariceta G, Villate A. Chloride deficiency as a presentation or complication of cystic fibrosis. Eur J Pediatr 1994; 153: 825–8.
Ballestero Y, Hernandez MI, Rojo P et al. Hyponatremic dehydration as presentation of cystic fibrosis. Pediatr Emerg Care 2006; 22: 725–7.
Kaskavage J, Sklansky D. Hyponatremia-associated rhabdomyolysis following exercise in an adolescent with cystic fibrosis. Pediatrics 2012; 130: e220–3.
Augusto JF, Sayegh J, Malinge MC, Illouz F, Subra JF, Ducluzeau PH. Severe episodes of extra cellular dehydration: an atypical adult presentation of cystic fibrosis. Clin Nephrol 2008; 69: 302–5.
Nahida el-R, Mohammed H, Guy L. Pseudo-Bartter’s syndrome revealing cystic fibrosis in an infant caused by 3849 + 1G>A and 4382delA compound heterozygosity. Acta Paediatr 2011; 100: e234–5.
Aranzamendi RJ, Breitman F, Asciutto C, Delgado N, Castaños C. Dehydration and metabolic alkalosis: an unusual presentation of cystic fibrosis in an infant. Arch Argent Pediatr 2008; 106: 443–6.
Kessler WR, Andersen DH. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics 1951; 8: 648–55.
Davis PB, di Sant’Agnese PA. Diagnosis and treatment of cystic fibrosis. An update. Chest 1984; 85(6): 802–9.
Borinc BA, Brecelj J, Bratanič N, Homan M, Homšak M, Jenko K et al. Smernice za obravnavo otrok s cistično fibrozo. Zdrav Vestn 2008; 77: 679–92.
Holland AE, Wilson JW, Kotsimbos TC et al. Metabolic alkalosis contributes to acute hypercapnic respiratory failure in adult cystic fibrosis. Chest 2003; 124: 490–3.
Kriemler S, Wilk B, Schurer W, Wilson WM, Bar-Or O. Preventing dehydration in children with cystic fibrosis who excercise in the heat. Med Sci Sports Exerc 1999; 31: 774–9.
http://netscut.templaro.com/fen/hyponatremic_dehidration.html.
Mackway-Jones K, Molyneux E, Phillips B, Wieteska S. Advanced paediatric life support. 5th ed. Malden: Blackwell Publishing Ltd; 2011.
www.health.qld.gov.au/masters/copyright.asp.
Gavin JE. Nutritional Management. In: Hill CM, editor. Practical guidelines for cystic fibrosis care. London: Churchill Livingstone; 1998; p.65–78.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
